Clinical radiobiology of glioblastoma multiforme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical radiobiology of glioblastoma multiforme

Published:2014-04-04 Issue:10 Volume:190 Page:925-932
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Pedicini Piernicola,Fiorentino Alba,Simeon Vittorio,Tini Paolo,Chiumento Costanza,Pirtoli Luigi,Salvatore Marco,Storto Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00066-014-0638-9.pdf

Reference32 articles.

1. Balducci M, Apicella G, Manfrida S, Mangiola A, Fiorentino A, Azario L, D’Agostino GR, Frascino V, Dinapoli N, Mantini G, Albanese A, de Bonis P, Chiesa S, Valentini V, Anile C, Cellini N (2010) Single-Arm Phase II Study of Conformal Radiation Therapy and Temozolomide plus fractionated Stereotactic Conformal Boost in High grade Gliomas. Strahlen Onkol 186(10):558–564

2. Balducci M, Chiesa S, Diletto B, D’Agostino GR, Mangiola A, Manfrida S, Mantini G, Albanese A, Fiorentino A, Frascino V, De Bari B, Micciche F, De Rose F, Morganti AG, Anile C, Valentini V (2012) Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study. Neuro Oncol 14(1):79–86

3. Balducci M, Fiorentino A, De Bonis P, Chiesa S, Mangiola A, Mattiucci GC, D’Agostino GR, Frascino V, Mantini G, Alitto AR, Colosimo C, Anile C, Valentini V (2013) Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials. Strahlen Onkol 189(11):926–931

4. Bao S, Wu Q, Mc Lendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756–760

5. Buckner JV, Ballman KV, Michalak JC, Burton GV, Cascino TL, Schomberg PJ, Hawkins RB, Scheithauer BW, Sandler HM, Marks RS, O’Fallon JR, North Central Cancer Treatment Group 93–72-52, Southwest Oncology Group 9503 Trials (2006) Phase III Trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93–72-52 and Southwest Oncology Group 9503 Trials. J Clin Oncol 24(24):3871–3879

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a Balloon Implant for Simultaneous Magnetic Nanoparticle Hyperthermia and High-Dose-Rate Brachytherapy of Brain Tumor Resection Cavities;Cancers;2023-12-01

2. Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial;Journal of Neuro-Oncology;2023-07-15

3. Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study;The British Journal of Radiology;2023-06-01

4. Stereotactic radiosurgery for distant punctate recurrent IDH-wild type glioblastoma: a single institution experience;2023-04-13

5. Optimal Levels of Isoeffective Doses for Two Fractionation Modes in Glioblastoma;Meditsinskaya Fizika;2023-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3